2-methoxyestradiol blocks estrogen-induced rat pituitary tumor growth and tumor angiogenesis: Possible role of vascular endothelial growth factor

Anticancer Research

Volumn 20, Issue 4, 2000, Pages 2641-2645

  Banerjee, Sushanta K ^a   Zoubine, Mikhail N ^a,b   Sarkar, Dipak K ^c   Weston, Allan P ^a,b   Shah, Jamshed H ^d   Campbell, Donald R ^a,b  

^a VA Medical Center   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d ENTREMED INC   (United States)

Author keywords

2 Methoxystradiol; Augiogenesis; Estcogen; Pituitary tumor; VEGF

Indexed keywords

2 METHOXYESTRADIOL; CYCLINE; ESTRADIOL; ESTROGEN; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONAL CARCINOGENESIS; HYPOPHYSIS TUMOR; IMMUNOHISTOCHEMISTRY; LABELING INDEX; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTICARCINOGENIC AGENTS; BODY WEIGHT; ENDOTHELIAL GROWTH FACTORS; ESTRADIOL; FEMALE; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; PITUITARY NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, INBRED F344; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033863030     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Brueggemeier RW, Singh U: Inhibition of rat liver microsomal estrogen 2-hydroxylase by 2- methoxyestrogens. J Steroid Biochem 33: 589-593, 1989.
2. Zhu BT, Conney AH: Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res 58: 2269-2277, 1998.
3. Gelbke HP, Knuppen R: The excretion of five different 2-hydroxyoestrogen monomethyl ethers in human pregnancy urine. J Steroid Biochem 7: 457-463, 1976.
4. Zoubine MN, Weston AP, Johnson DC, Campbell DR, Banerjee SK: 2-methoxyestradiol- induced growth suppression and lethality in estrogen- responsive MCF-7 cells may be mediated by down regulation of p34cdc2 and cyclin B1 xpression. Int J Oncol 15: 639-646, 1999.
5. Lottering ML, de Kock M, Viljoen TC, Grobler CJ, Seegers JC: 17beta-Estradiol metabolites affect some regulators of the MCF-7 cell cycle. Cancer Lett 110: 181-186, 1996.
6. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, Schweigerer L: The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368: 237-239, 1994.
7. Klauber N, Parangi S, Flynn E, Hamel E, D'Amato RJ: Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res 57: 81-86, 1997.
8. Arbiser JL, Panigrathy D, Klauber N, Rupnick M, Flynn E, Udagawa T, D'Amato RJ: The antiangiogenic agents TNP-470 and 2-methoxyestradiol inhibit the growth of angiosarcoma in mice. J Am Acad Dermatol 40: 925-929, 1999.
9. Schumacher G, Kataoka M, Roth JA, Mukhopadhyay T: Potent antitumor activity of 2- methoxyestradiol in human pancreatic cancer cell lines. Clin Cancer Res 5: 493-499, 1999.
10. Furth J, Clifton KH: Experimental pituitary tumors, In: Harris GW, Donovan BT (eds) The pituitary glands, London, 1966, pp 460-497
11. Lloyd RV: Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study. Am J Pathol 113: 198-206, 1983.
12. Sarkar DK, Gottschall PE, Meites J: Relation of the neuroendocrine system to development of prolactin-secreted pituitary tumors, In: Meites J (ed) Neuroendocrinology and Aging, New york, 1983, pp 353-376.
13. Banerjee SK, De A, Sarkar DK: Colocalization of prolactin and proliferating cell nuclear antigen in the anterior pituitary during estrogen-induced pituitary tumors. Cancer Lett 87: 139-144, 1994.
14. Banerjee SK, Sarkar DK, Weston AP, De A, Campbell DR: Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis. Carcinogenesis 18: 1155-1161, 1997.
15. Stepien H, Grochal M, Zielinski KW, Mucha S, Kunert-Radek J, Kulig A, Stawowy A, Pisarek H: Inhibitory effects of fumagillin and its analogue TNP-470 on the function, morphology and angiogenesis of an oestrogen-induced prolactinoma in Fischer 344 rats. J Endocrinol 150: 99-106, 1996.
16. Takechi A, Uozumi T, Kawamoto K, Ito A, Kurisu K, Sudo K: Inhibitory effect of TNP-470, a new anti-angiogenic agent, on the estrogen induced rat pituitary tumors. Anticancer Res 14: 157-162, 1994.
17. Elias KA, Weiner RI: Direct arterial vascularization of estrogen-induced prolactin-secreting anterior pituitary tumors. Proc Natl Acad Sci USA 81: 4549-4553, 1984.
18. Banerjee SK, Zoubine MN, Tran TM, Weston AP, Campbell DR: Overexpression of vascular endothelial growth factor164 and its coreceptor neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells [In Process Citation]. Int J Oncol 16: 253-260, 2000.
19. Spady TJ, Lemus-Wilson AM, Pennington KL, Blackwood DJ, Paschall TM, Birt DF, McComb RD, Shull JD: Dietary energy restriction abolishes development of prolactin- producing pituitary tumors in Fischer 344 rats treated with 17beta-estradiol. Mol Carcinog 23: 86-95, 1998.